Opinion
Video
Factors Guiding Treatment Selection in Adult Spinal Muscular Atrophy
Panelists explore critical considerations when choosing a treatment approach for treatment-naïve adult patients with spinal muscular atrophy (SMA), taking into account factors such as disease severity, patient preferences, and potential treatment outcomes.
Video Player is loading.
- What factors guide choice of therapy in treatment naïve adult patients?
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Related Videos
Validating a Wearable-Based Classifier to Detect iRBD: Emmanuel During, MD
Expert Perspectives on The Importance of Multidisciplinary Care for Patients With Duchenne Muscular Dystrophy
The Future of Duchenne Muscular Dystrophy Treatment: Expert Insights on Gene Therapy
Sharing Treatment Strategies for Patients With Parkinson Disease Beyond Medication: Esther Labib-Kiyarash, MSHA, CPHQ
Increased Awareness for Essential Tremor Treatment, MR-guided Focused Ultrasound: Justin Martello, MD
Understanding the Phenomenology and Impact of Psychosis in Parkinson Disease: William Ondo, MD
Incorporating Palliative Care Principles into Movement Disorder Management: Jennifer Corcoran, MD
Improving the Management of Parkinson Through Psychological Interventions: Marcia Pasqualini, PhD
Integrating Experiential and Holistic Approaches in Parkinson Disease Management: Anissa Mitchell, LCSW
Eptinezumab Improves Medication Overuse Headache, Submission for GTx-104 in Subarachnoid Hemorrhage, FDA Expands Indication for Vizamyl PET Imaging
Related Content
